| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Mark R Schleiss | Q91191877 |
| P2860 | cites work | The guinea-pig is not a rodent | Q28279579 |
| Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice | Q30435035 | ||
| Complete DNA sequence of the rat cytomegalovirus genome | Q33810063 | ||
| Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. | Q33833779 | ||
| Recognition of a virus-encoded ligand by a natural killer cell activation receptor | Q34066048 | ||
| Recent advances in herpesvirus genetics using bacterial artificial chromosomes | Q34132209 | ||
| Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication | Q34338715 | ||
| Progress toward an elusive goal: current status of cytomegalovirus vaccines | Q34434818 | ||
| Pathogenesis of murine cytomegalovirus infection | Q35586488 | ||
| Guinea pig and chinchilla care and husbandry. | Q35774289 | ||
| Stalemating a clever opportunist: lessons from murine cytomegalovirus | Q35789344 | ||
| Structural and functional aspects of the Ly49 natural killer cell receptors | Q36015056 | ||
| Listeriosis in the pregnant guinea pig: a model of vertical transmission | Q36227927 | ||
| Neuropathogenesis in cytomegalovirus infection: indication of the mechanisms using mouse models | Q36229534 | ||
| Experimental transplacental transmission of porcine cytomegalovirus | Q36250859 | ||
| Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen | Q36351047 | ||
| Nonhuman primate models of intrauterine cytomegalovirus infection | Q36359753 | ||
| Serological Studies on the Major Histocompatibility Complex of New Inbred Strains of the Guinea Pig1 | Q39525470 | ||
| Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. | Q39789433 | ||
| Susceptibility of porcine cytomegalovirus to antiviral drugs | Q40561290 | ||
| Placental structure: in a comparative aspect | Q40652227 | ||
| Cloning and expression of the guinea pig cytomegalovirus glycoprotein B (gB) in a recombinant baculovirus: utility for vaccine studies for the prevention of experimental infection | Q40673290 | ||
| Guinea pigs | Q40715148 | ||
| Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors | Q40738490 | ||
| Replication-defective mutants of mouse cytomegalovirus protect against wild-type virus challenge | Q40852958 | ||
| Reduced Congenital Cytomegalovirus (CMV) Infection after Maternal Immunization with a Guinea Pig CMV Glycoprotein before Gestational Primary CMV Infection in the Guinea Pig Model | Q41277274 | ||
| Postnatal porencephaly induced in mouse by murine cytomegalovirus | Q42463983 | ||
| A novel CC-chemokine homolog encoded by guinea pig cytomegalovirus | Q42604389 | ||
| A macrophage inflammatory protein homolog encoded by guinea pig cytomegalovirus signals via CC chemokine receptor 1. | Q42614244 | ||
| Vaccination for the Prevention of Maternal and Fetal Infection with Guinea Pig Cytomegalovirus | Q43467430 | ||
| Early-stage developmental abnormalities induced by murine cytomegalovirus | Q44029242 | ||
| Brain abnormalities induced by murine cytomegalovirus injected into the cerebral ventricles of mouse embryos exo utero | Q44540858 | ||
| Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial | Q44547726 | ||
| Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine | Q45069922 | ||
| Development of respiratory syncytial virus "bronchiolitis" in guinea pigs does not reflect an allergic predisposition in the host | Q45722299 | ||
| Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. | Q45881220 | ||
| Congenital cytomegalovirus labyrinthitis and sensorineural hearing loss in guinea pigs. | Q45938787 | ||
| Growth of Listeria monocytogenes in the guinea pig placenta and role of cell-to-cell spread in fetal infection | Q46339471 | ||
| Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection | Q46347804 | ||
| Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection | Q46462019 | ||
| Intracerebral infection with murine cytomegalovirus induces CXCL10 and is restricted by adoptive transfer of splenocytes | Q47325477 | ||
| Human cytomegalovirus virion proteins | Q47408220 | ||
| Identification of essential and non-essential genes of the guinea pig cytomegalovirus (GPCMV) genome via transposome mutagenesis of an infectious BAC clone | Q47891874 | ||
| The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome | Q48264323 | ||
| Brain and visceral involvement during congenital cytomegalovirus infection of guinea pigs | Q48940949 | ||
| P433 | issue | 1 | |
| P921 | main subject | Cytomegalovirus | Q6946 |
| pathogenesis | Q372016 | ||
| congenital disorder | Q727096 | ||
| prevention | Q1717246 | ||
| P304 | page(s) | 65-72 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | ILAR Journal | Q15756706 |
| P1476 | title | Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns | |
| P478 | volume | 47 |
| Q36517130 | A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection |
| Q37508272 | An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model |
| Q37127280 | An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model |
| Q35764653 | An in vitro mouse model of congenital cytomegalovirus-induced pathogenesis of the inner ear cochlea |
| Q90062915 | Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development |
| Q36240617 | Antagonism of the protein kinase R pathway by the guinea pig cytomegalovirus US22-family gene gp145. |
| Q36862161 | Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis |
| Q42267802 | Characterization of the guinea pig CMV gH/gL/GP129/GP131/GP133 complex in infection and spread |
| Q45942829 | Characterization of the guinea pig cytomegalovirus genome locus that encodes homologs of human cytomegalovirus major immediate-early genes, UL128, and UL130. |
| Q36633558 | Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection aga |
| Q34354971 | Complete genome sequence of cell culture-attenuated Guinea pig cytomegalovirus cloned as an infectious bacterial artificial chromosome |
| Q37406553 | Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis |
| Q34885438 | Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model |
| Q37574334 | Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next? |
| Q42273557 | Establishment of rat brain endothelial cells susceptible to rat cytomegalovirus ALL-03 infection. |
| Q47779280 | Founders of Pediatric Pathology: Margaret G. Smith and John M. Kissane |
| Q37415756 | Genome Sequence of a Novel, Newly Identified Isolate of Guinea Pig Cytomegalovirus, the CIDMTR Strain |
| Q37488267 | Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model |
| Q36517126 | Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission |
| Q39629189 | Guinea pig cytomegalovirus GP84 is a functional homolog of the human cytomegalovirus (HCMV) UL84 gene that can complement for the loss of UL84 in a chimeric HCMV |
| Q30457383 | Hearing loss in children with very low birth weight: current review of epidemiology and pathophysiology |
| Q35099535 | How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance |
| Q37807749 | Human cytomegalovirus immunity and immune evasion |
| Q37713890 | Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA. |
| Q38166925 | Human cytomegalovirus manipulation of latently infected cells |
| Q35899274 | Human cytomegalovirus persistence |
| Q41773417 | Identification by mass spectrometry and immune response analysis of guinea pig cytomegalovirus (GPCMV) pentameric complex proteins GP129, 131 and 133. |
| Q39957297 | Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture |
| Q27026924 | Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model |
| Q96577451 | Impairment in neurocognitive function following experimental neonatal guinea pig cytomegalovirus infection |
| Q37243886 | Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity. |
| Q34708600 | Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model |
| Q27320190 | Listeria monocytogenes traffics from maternal organs to the placenta and back |
| Q38257810 | Models of vertical cytomegalovirus (CMV) transmission and pathogenesis |
| Q37611802 | Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus |
| Q27320589 | Murine CMV-induced hearing loss is associated with inner ear inflammation and loss of spiral ganglia neurons |
| Q59356361 | Murine cytomegalovirus M72 promotes acute virus replication in vivo and is a substrate of the TRiC/CCT complex |
| Q36059847 | Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette |
| Q46825500 | Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine |
| Q36517156 | VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection |
Search more.